# Actuate Therapeutics, Inc.: Form SCHEDULE 13D/A, filed May 27, 2025

- Company: [Actuate Therapeutics, Inc.](/companies/actu.md) (CIK 1652935)
- Form: SCHEDULE 13D/A
- Filed: 2025-05-27
- Accepted by EDGAR: May 27, 2025, 16:15 ET
- Period: not reported
- Accession: 0001104659-25-052987
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1652935/000110465925052987/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1652935/000110465925052987/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1652935/000110465925052987/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 27, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-052987. Last ingested by Listed: Nov 2, 2026, 18:06 ET. No prices; not investment advice.